Lin, Guizhong – Trademark Portfolio

Entity Type: 01

Lin, Guizhong holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. The portfolio also extends into Class 30 (Staple Foods) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include KSEONDI and GVEAZIOD. The owner is based in Fujian Province.

Minqing County

No.29 Jiefang Street, Meicheng Town

Fujian Province 350800 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

KSEONDI
KSEONDI
Registered 2025
GVEAZIOD
GVEAZIOD
Registered 2024

Trademark Classifications

Lin, Guizhong's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

30
Staple Foods (1 filing)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

Frequently Asked Questions

How many trademarks does Lin, Guizhong have?

Lin, Guizhong has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Lin, Guizhong file in?

Lin, Guizhong files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Lin, Guizhong's most well-known trademarks?

Lin, Guizhong's registered trademark portfolio includes well-known marks such as KSEONDI and GVEAZIOD. These are among 2 currently registered trademarks in the portfolio.

What is Lin, Guizhong's trademark registration success rate?

Lin, Guizhong has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.